Medexus Pharma Competitors and Similar CompaniesClear all

Medexus Pharma's competitors and similar companies include Medios, ORIC Pharmaceuticals, Baudax Bio and Biomedix Group.

	Medexus Pharma Medexus Pharma is a pharmaceutical company.	Medios Medios is a manufacturer and supplier of pharmaceutical products.	ORIC Pharmaceuticals ORIC is a pharmaceutical company dedicated to discovering and developing therapies towards overcoming resistance in cancer.	Baudax Bio Baudax Bio is a pharmaceutical company that focuses on developing and commercializing products for patients in acute care settings.	Biomedix Group Biomedix Group is a pharmaceutical company.
Founding Date	Founding Date 2013	Founding Date 2016	Founding Date 2014	Founding Date 2019	Founding Date N/A
Type	Type Public	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare oncology pharma	Tags Healthcare oncology pharma	Tags Healthcare oncology pharma	Tags Healthcare oncology pharma	Tags Healthcare oncology pharma
Locations	Locations Chicago, US HQ Bolton, CA	Locations Berlin, DE HQ Berlin, DE	Locations South San Francisco, US HQ San Diego, US	Locations Malvern, US HQ	Locations Borehamwood, GB HQ
Employees	Employees 98	Employees 515	Employees 57	Employees 20	Employees 13
Valuation ($)	Valuation ($) 45.5 m	Valuation ($) N/A	Valuation ($) 634.9 m	Valuation ($) 8.1 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $108.3m (FY, 2025)	Revenue (est.) €2.1b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $1.3m (FY, 2022)	Revenue (est.) N/A
Cost of goods	Cost of goods $44.8m (FY, 2025)	Cost of goods €1.9b (FY, 2025)	Cost of goods N/A	Cost of goods $7m (FY, 2022)	Cost of goods N/A
Gross profit	Gross profit $63.5m (FY, 2025)	Gross profit €200.1m (FY, 2025)	Gross profit N/A	Gross profit ($5.7m) (FY, 2022)	Gross profit N/A
Net income	Net income $2.2m (FY, 2025)	Net income €15.4m (FY, 2025)	Net income ($129.5m) (FY, 2025)	Net income ($58.8m) (FY, 2022)	Net income N/A